Contract Research & Development
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
48
NCT02340572
First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PRS-080
Phase: Phase 1
Role: Collaborator
Start: Nov 30, 2014
Completion: Aug 31, 2015
Loading map...